- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Hon’ble NCLT has approved the resolution plan for Parenteral Drugs (India) Ltd. as part of its corporate insolvency resolution process (CIRP). This approval indicates a pathway for the company to stabilize and potentially restore operations post-insolvency, which may enhance its financial health and governance structures. Investors might view this development positively, as successful implementation of the resolution plan could lead to a recovery trajectory for the company, presenting new opportunities while maintaining a watchful eye on operational adjustments and risks associated with the ongoing transition.